{"ABT": {"Ticker": "ABT", "Company": "Abbott Laboratories", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$118"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$110"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Barclays"], "Price_Target": 114.0}, "BAX": {"Ticker": "BAX", "Company": "Baxter International", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$64"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$62"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Barclays"], "Price_Target": 63.0}, "BSX": {"Ticker": "BSX", "Company": "Boston Scientific", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$49"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$50"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Jefferies", "Barclays"], "Price_Target": 49.5}, "CHD": {"Ticker": "CHD", "Company": "Church & Dwight", "Sector": "Consumer Staples", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Evercore ISI", "Rating_Change": "In-line", "Target_Change": ""}, {"Date": "2022-10-17", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$82"}, {"Date": "2022-10-05", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$90 to $85"}, {"Date": "2022-09-14", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Underperform", "Target_Change": "$75"}, {"Date": "2022-09-08", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Evercore ISI", "Deutsche Bank", "Morgan Stanley", "BofA Securities", "Truist"], "Price_Target": 80.67}, "CLX": {"Ticker": "CLX", "Company": "Clorox", "Sector": "Consumer Staples", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Evercore ISI", "Rating_Change": "Underperform", "Target_Change": ""}, {"Date": "2022-10-17", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$130"}, {"Date": "2022-09-14", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Underperform", "Target_Change": "$130"}], "Score": -0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Evercore ISI", "Morgan Stanley", "BofA Securities"], "Price_Target": 130.0}, "DXCM": {"Ticker": "DXCM", "Company": "DexCom", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$103"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$125"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Barclays"], "Price_Target": 114.0}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$96"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$110"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Buy to Hold", "Target_Change": "$115 to $106"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Canaccord Genuity", "Jefferies", "Barclays"], "Price_Target": 104.0}, "EOG": {"Ticker": "EOG", "Company": "EOG Resources", "Sector": "Energy", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$125 to $143"}, {"Date": "2022-09-20", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$157"}, {"Date": "2022-09-19", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$119 to $134"}, {"Date": "2022-09-15", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$152 to $156"}, {"Date": "2022-08-05", "Rating": "Upgrade", "Organization": "TD Securities", "Rating_Change": "Hold to Buy", "Target_Change": "$135"}], "Score": 1.8, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "A", "Analists": ["KeyBanc Capital Markets", "TD Securities", "Goldman", "JP Morgan", "BofA Securities"], "Price_Target": 145.0}, "GPN": {"Ticker": "GPN", "Company": "Global Payments", "Sector": "Information Technology", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Downgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform to Neutral", "Target_Change": "$115"}, {"Date": "2022-07-22", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$180 to $145"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Credit Suisse", "Exane BNP Paribas"], "Price_Target": 130.0}, "IP": {"Ticker": "IP", "Company": "International Paper", "Sector": "Materials", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Sell", "Target_Change": "$44 to $29"}, {"Date": "2022-09-16", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Underperform", "Target_Change": "$40 to $31"}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Deutsche Bank", "Jefferies"], "Price_Target": 30.0}, "ISRG": {"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$235"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$215"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$210"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Mizuho", "Jefferies", "Barclays"], "Price_Target": 220.0}, "JNJ": {"Ticker": "JNJ", "Company": "Johnson & Johnson", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$175"}, {"Date": "2022-10-14", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$185 to $178"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Barclays", "BofA Securities"], "Price_Target": 176.5}, "JNPR": {"Ticker": "JNPR", "Company": "Juniper Networks", "Sector": "Information Technology", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Underweight to Neutral", "Target_Change": "$27 to $29"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Piper Sandler"], "Price_Target": 29.0}, "KMB": {"Ticker": "KMB", "Company": "Kimberly-Clark", "Sector": "Consumer Staples", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Evercore ISI", "Rating_Change": "In-line", "Target_Change": ""}, {"Date": "2022-10-12", "Rating": "Upgrade", "Organization": "Atlantic Equities", "Rating_Change": "Neutral to Overweight", "Target_Change": "$135"}, {"Date": "2022-09-14", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$130"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Evercore ISI", "Atlantic Equities", "BofA Securities"], "Price_Target": 132.5}, "MAS": {"Ticker": "MAS", "Company": "Masco", "Sector": "Industrials", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$58 to $46"}, {"Date": "2022-08-18", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$61"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Deutsche Bank", "BofA Securities"], "Price_Target": 53.5}, "MDT": {"Ticker": "MDT", "Company": "Medtronic", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$90"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$100"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$87"}, {"Date": "2022-08-24", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Mizuho", "Jefferies", "Barclays", "Raymond James"], "Price_Target": 92.33}, "MHK": {"Ticker": "MHK", "Company": "Mohawk Industries", "Sector": "Consumer Discretionary", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$140 to $100"}, {"Date": "2022-08-18", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$122"}, {"Date": "2022-08-01", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Strong Buy to Mkt Perform", "Target_Change": ""}], "Score": -1.33, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Deutsche Bank", "Raymond James", "BofA Securities"], "Price_Target": 111.0}, "NVR": {"Ticker": "NVR", "Company": "NVR", "Sector": "Consumer Discretionary", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$4900"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["BofA Securities"], "Price_Target": 4900.0}, "PKG": {"Ticker": "PKG", "Company": "Packaging Corporation of America", "Sector": "Materials", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Sell", "Target_Change": "$144 to $104"}, {"Date": "2022-09-16", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Underperform", "Target_Change": "$130 to $112"}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Deutsche Bank", "Jefferies"], "Price_Target": 108.0}, "SPG": {"Ticker": "SPG", "Company": "Simon Property Group", "Sector": "Real Estate", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wolfe Research"], "Price_Target": 0}, "SYK": {"Ticker": "SYK", "Company": "Stryker Corporation", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$239"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$270"}, {"Date": "2022-07-28", "Rating": "Upgrade", "Organization": "Edward Jones", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-07-21", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$285 to $205"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Deutsche Bank", "Jefferies", "Barclays", "Edward Jones"], "Price_Target": 238.0}, "TGT": {"Ticker": "TGT", "Company": "Target Corporation", "Sector": "Consumer Discretionary", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$170 to $185"}, {"Date": "2022-09-14", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$200"}, {"Date": "2022-08-18", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Hold", "Target_Change": "$150 to $165"}, {"Date": "2022-08-18", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$231 to $223"}, {"Date": "2022-08-18", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Strong Buy", "Target_Change": "$190 to $200"}, {"Date": "2022-08-18", "Rating": "Reiterated", "Organization": "MKM Partners", "Rating_Change": "Neutral", "Target_Change": "$163 to $161"}, {"Date": "2022-08-18", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$161 to $170"}, {"Date": "2022-08-18", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$155 to $205"}, {"Date": "2022-08-18", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$195 to $193"}, {"Date": "2022-08-18", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$165 to $180"}, {"Date": "2022-08-01", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$195"}, {"Date": "2022-07-22", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$190"}], "Score": 0.92, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 12, "Period": "180 days", "Letter_Rating": "B", "Analists": ["KeyBanc Capital Markets", "Raymond James", "Deutsche Bank", "MKM Partners", "RBC Capital Mkts", "Piper Sandler", "BofA Securities", "Goldman", "Jefferies", "Truist", "Wells Fargo"], "Price_Target": 188.92}, "XYL": {"Ticker": "XYL", "Company": "Xylem", "Sector": "Industrials", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Upgrade", "Organization": "Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$85 to $105"}, {"Date": "2022-08-03", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Underperform to Neutral", "Target_Change": "$77 to $96"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Credit Suisse", "Cowen"], "Price_Target": 100.5}, "ZBH": {"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-10-18", "Rating": [{"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$104"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Underperform", "Target_Change": "$95"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Jefferies", "Barclays"], "Price_Target": 99.5}}